Sta znaci na Engleskom BILE SU UMOR - prevod na Енглеском

• were fatigue
• were tiredness

Примери коришћења Bile su umor на Хрватском и њихови преводи на Енглески

Najčešće prijavljene nuspojave bile su umor, glavobolja i mučnina.
The most frequently reported adverse reactions were fatigue, headache, and nausea.

U ispitanika koji su primali lijekove Viekirax i dasabuvir s ribavirinom, najčešće prijavljivane nuspojave(prijavljene u više od 20% ispitanika) bile su umor i mučnina.
In subjects receiving Viekirax and dasabuvir with ribavirin, the most commonly reported adverse reactions(greater than 20% of subjects) were fatigue and nausea.

Najčešće prijavljene nuspojave bile su umor, anemija(vidjeti dio 4.4), mučnina, glavobolja i disgeuzija.
The most frequently reported adverse reactions were fatigue, anaemia(see section 4.4), nausea, headache, and dysgeusia.

Najčešće prijavljene nuspojave kod primjene lijeka, a koje su češće u odnosu na placebo, bile su umor(1,2%), suha usta(0,8%) i glavobolja 0, 6.
The most frequent of adverse events reported in excess of placebo were fatigue(1.2%), dry mouth(0.8%) and headache 0.6.

Najčešće prijavljene nuspojave bile su umor, glavobolja, pruritus, anemija, bolest nalik gripi, mučnina, nesanica, neutropenija, astenija, osip, smanjen tek, suha koža, alopecija, pireksija, mialgija, razdražljivost, kašalj, proljev, dispneja i artralgija.
The most frequently reported adverse reactions were fatigue, headache, pruritus, anaemia, influenza- like illness, nausea, insomnia, neutropenia, asthenia, rash, decreased appetite, dry skin, alopecia, pyrexia, myalgia, irritability, cough, diarrhoea, dyspnoea and arthralgia.

Najčešće nuspojave stupnja 3/4 koje su se javile u ≥ 2% bolesnika liječenih Odomzom 200 mg bile su umor, smanjena tjelesna težina i mišićni spazmi.
The most common grade 3/4 adverse drug reactions occurring in≥2% of patients treated with Odomzo 200 mg were fatigue, weight decreased and muscle spasms.

Nuspojave koje su često zabilježene u kliničkim ispitivanjima s lijekom Zeffix bile su umor, infekcije dišnih puteva, neugoda u grlu, glavobolja, neugoda i bol u želucu, mučnina, povraćanje i proljev, povišene vrijednosti jetrenih enzima i enzima koje proizvode mišići pogledajte tekst ispod.
Side effects that were commonly reported in Zeffix clinical trials were tiredness, respiratory tract infections, throat discomfort, headache, stomach discomfort and pain, nausea, vomiting and diarrhoea, increases in liver enzymes and enzymes produced in the muscles see below.

U bolesnika koji su prethodno liječeni protiv HIV-a najčešće nuspojave(zabilježene u više od 2 na 100 bolesnika) bile su umor, proljev, mučnina i nesanica.
In patients who had received previous HIV treatment, the most common side effects(seen in more than 2 patients in 100) were tiredness, diarrhoea, nausea and insomnia.

U ispitivanju primjene lijeka Tarceva u kombinaciji s gemcitabinom u bolesnika s rakom gušterače najčešće nuspojave bile su umor(zabilježen u 73% bolesnika), osip(zabilježen u 69% bolesnika) i proljev zabilježen u 48% bolesnika.
In the study of Tarceva used in combination with gemcitabine for pancreatic cancer, the most common side effects were tiredness(seen in 73% of patients), rash(seen in 69% of patients) and diarrhoea seen in 48% of patients.

Najčešće nuspojave u središnjem ispitivanju PA.3 u bolesnika s rakom gušterače koji su primali lijek Tarceva 100 mg u kombinaciji s gemcitabinom bile su umor, osip i proljev.
The most common adverse reactions in pivotal study PA.3 in pancreatic cancer patients receiving Tarceva 100 mg plus gemcitabine were fatigue, rash and diarrhoea.

Tijekom drugog ciklusa liječenja, u kojem su svi lijekovi primijenjeni istoga dana, najčešće reakcije na infuziju u skupini liječenoj lijekom Perjeta(≥ 1,0%) bile su umor, disgeuzija, preosjetljivost na lijek, mialgija i povraćanje vidjeti dio 4.4.
During the second cycle when all medicinal products were administered on the same day, the most common infusion reactions in the Perjeta-treated group(≥ 1.0%) were fatigue, dysgeusia, drug hypersensitivity, myalgia and vomiting see section 4.4.

U objedinjenim podacima iz dvaju ispitivanja provedenih u bolesnika sa planocelularnim NSCLC-om(CA209017 i CA209063), najčešće nuspojave(≥ 10% bolesnika) bile su umor(33%), smanjen tek(15%) i mučnina 12.
In the pooled dataset of two studies in squamous NSCLC(CA209017 and CA209063), the most frequent adverse reactions(≥ 10% of patients) were fatigue(33%), decreased appetite(15%), and nausea 12.

Najčešće prijavljene nuspojave bile su reakcije na infuziju(48%); vidjeti dio 4.4. Ostale često prijavljene nuspojave(≥ 20%) bile su umor(39%), pireksija(21%), kašalj(21%), mučnina(27%).
The most frequently reported adverse reactions were IRRs(48%); see section 4.4. Other frequently reported adverse reactions(≥ 20%) were fatigue(39%), pyrexia(21%), cough(21%), nausea 27.

Najčešće nuspojave na lijek koje su nastajale u ispitanika koji su primali sofosbuvir i ribavirin ili sofosbuvir, ribavirin i peginterferon alfa bile su umor, glavobolja, mučnina i nesanica.
The most common adverse drug reactions occurring in subjects receiving sofosbuvir and ribavirin or sofosbuvir, ribavirin and peginterferon alfa were fatigue, headache, nausea and insomnia.

Najčešće nuspojave prijavljene u kliničkim ispitivanjima, povezane s liječenjem lijekom PegIntron u kombinaciji s ribavirinom u odraslih bolesnika i opažene u više od polovice ispitanika, bile su umor, glavobolja i reakcije na mjestu injiciranja.
The most common treatment-related adverse reactions reported during clinical trials with PegIntron in combination with ribavirin in adults, seen in more than half of the study subjects, were fatigue, headache, and injection site reaction.

Studija faze I odredila je važeći režim evaluacijom kohorte lijeka Teysuno i cisplatina u dozama od 30 mg/m2 i 60 mg/m2(uočene toksičnosti koje su ograničavale dozu[DLT od engl. dose-limiting toxicities] bile su umor, proljev i dehidracija); 25 mg/m2 i 60 mg/m2; i 25 mg/m2 i 75 mg/m2.
A Phase I study established the current regimen by evaluating cohorts of Teysuno and cisplatin of 30 mg/m2 and 60 mg/m2(dose-limiting toxicities[DLTs] seen were fatigue, and diarrhoea and dehydration); 25 mg/m2 and 60 mg/m2; and 25 mg/m2 and 75 mg/m2.

Najčešće nuspojave su bile umor, poremećaji probavnoga sustava, hematološki, respiratorni i neurološki poremećaji i pireksija.
The most frequently occurring adverse events were fatigue; gastrointestinal disorders; haematological disorders; respiratory disorders; nervous system disorders; and pyrexia.

Nije potrebno da bi štenci za kontakt s potencijalnim izvorima zaraze, uz to potrebno je kako bi bili sigurni da je na ljubimac nije bio umor, hipotermija i stresnim situacijama.
Do not allow contact with puppies with suspected sources of infection, in addition, you must ensure that the pet does not have fatigue, hypothermia and stressful situations.

Mučili su je umor, bol u mišićima i slaba koncentracija.
Difficulty concentrating have been bothering her for over a year. The fatigue, muscle pain and.

Mucili su je umor, bol u misicima i slaba koncentracija.
The fatigue, muscle pain and difficulty concentrating have been bothering her for over a year.

Nije to. Mucili su je umor, bol u misicima i slaba koncentracija.
The fatigue, muscle pain and It's not a drug overdose.

Ovo nije umor.
This isn't tiredness.

U pitanju je umor.
Rheya, it's fatigue.

Moj problem je umor.
My problem is I'm tired.

Slušaj, to nije umor.
Listen, that's not fatigue.

Tu je umor, euforije.
There's fatigue, euphoria.

Osjetio sam umor.
I have felt a lethargy.

To je umor od bitke.
It's just a little battle fatigue.

Nije umor koji vas zaustaviti.
It's not exhaustion that stopped you.

Moj jedini problem je umor.
Sighs My only problem is that I'm tired.